Add Company
Join Now

Haima Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Haima Therapeutics's estimated annual revenue is currently $2.5M per year.(i)
  • Haima Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Haima Therapeutics has 16 Employees.(i)
  • Haima Therapeutics grew their employee count by -6% last year.

Haima Therapeutics's People

NameTitleEmail/Phone
1
Chief Operating OfficerReveal Email/Phone
2
Senior ScientistReveal Email/Phone
3
Research Scientist IIReveal Email/Phone
4
Senior Research ScientistReveal Email/Phone
5
Formulation Scientist IReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M50%N/AN/A
#2
$1.7M110%N/AN/A
#3
$0.8M50%N/AN/A
#4
$5.1M3314%N/AN/A
#5
$64.6M4172%N/AN/A
#6
$1.7M11-8%N/AN/A
#7
$0.8M50%N/AN/A
#8
$7.4M48-41%N/AN/A
#9
$0.6M40%N/AN/A
#10
$0.9M1220%N/AN/A
Add Company

What Is Haima Therapeutics?

Haima Therapeutics is a pre-clinical stage biotechnology company focused on developing bio-inspired therapies for the treatment of bleeding and other blood-related ailments. We have developed a novel, nanoparticle-based synthetic hemostatic technology, called SynthoPlate, that can staunch hemorrhagic bleeding by binding to the site of injury and amplifying your body's natural clotting mechanisms. Haima Therapeutics and Case Western Reserve University entered into an option to license agreement in April of 2018. Haima Therapeutics is located at the BioEnterprise incubator centrally located in the University Circle area near Case Western Reserve University, University Hospitals, and the Cleveland Clinic.

keywords:N/A

N/A

Total Funding

16

Number of Employees

$2.5M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.4M16-11%N/A
#2
$1.4M16N/AN/A
#3
$1.4M160%N/A
#4
N/A1678%N/A
#5
$1.4M16-20%N/A